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Abstract 
Expression of the insulin-like growth factor (IGF) system was investigated in mouse renal development and physiology, using 
non radioactive in situ hybridization and quantitative RT-PCR. IGF-I mRNA levels increased after birth and were confined to 
distal tubules and peritubular capillaries in the outer medulla. IGF-II mRNA levels were high in developing kidneys and peaked 
after birth. The type I receptor mRNA expression pattern mostly parallelled those of IGF-I and IGF-II. The IGF binding proteins 
(IGFBP's) showed weak mRNA expression for IGFBP-l and -6. High fetal mRNA levels were measured for IGFBP-2, showing 
a similar profile in time as observed for IGF-II. Low fetal IGFBP-3 and -5 mRNA levels increased after birth. IGFBP-2, - 4 and 
-5 mRNA expression was localized to differentiating cells. In the mature kidney predominant expression was confined to proximal 
tubules (IGFBP-4), thin limbs of Henle's Loop (IGFBP-2), glomerular mesangial cells (IGFBP-5) and peritubular capillaries of 
the medulla (IGFBP-5). IGFBP-3 mRNA was exclusively expressed in endothelial cells of the renal capillary system. Distinct 
mRNA expression for each member of the IGF system may point to specific roles in development and physiology of the mouse 
kidney. © 1997 Elsevier Science Ireland Ltd. 
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1. Introduction 
The development of the kidney is based on morpho-
genic processes that evolve in a sequential manner. 
After an inductive interaction of the epithelial cells of 
the ureter and the mesenchymal cells of the 
metanephros, both cell types start to proliferate and 
differentiate, finally leading to the formation of 
glomeruli and renal tubules (Saxen and Sariola, 1987). 
A number of polypeptide growth factors are involved 
in renal organogenesis. Epidermal growth factor 
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(EGF), transforming growth factors (TGFs), fibroblast 
growth factors (FGFs), platelet-derived growth factors 
(PDGFs) and insulin-like growth factors (IGFs) have 
been described in developmental studies for their regu-
latory roles in morphogenesis (Hammerman, 1995). 
Both IGF-I and IGF-II are single chain polypeptides 
which have mitogenic and differentiating effects on 
many cell types. IGF action is predominantly mediated 
through the type I receptor and the availability of the 
IGFs for the receptor is thought to be regulated by the 
IGF binding proteins (IGFBPs). 
The kidney is an obvious target of IGFs. In addition 
to circulating IGFs, local synthesis implies paracrine 
and autocrine IGF action as well. In the mature kidney 
IGFs can alter proximal tubular transport processes 
(Mellas et al., 1986; Rogers and Hammerman, 1989; 
Quigly and Baum, 1991; Caverzasio et al., 1990), stimu-
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late vectorial N a + transport (Blazer-Yost and Cox, 
1988; Blazer-Yost et ai., 1989) and control 
glomerular filtration rate and renal plasma flow 
levels (Hirschberg et ai., 1991, 1993). 
IGF-I and IGF-II have been detected in rat 
metanephroi (Rogers et ai., 1991) and abundant 
IGF-II expression was found in epithelial and mes-
enchymal cells of the nephrogenic zones in man 
(Matsell et ai., 1994). IGF-I expression was more 
prominent after development, mainly confined to 
the thick ascending limbs of Henle's Loop in both 
rat and man (Chin et ai., 1992; Rabkin et ai., 
1995). The type I IGF receptor is expressed in the 
rat mesonephros during early embryogenesis (Bondy 
et ai., 1990) and blocked expression in mouse kid-
ney organ cultures (Liu et ai., 1993) has demon-
strated its relevance in nephrogenesis. After 
development the type I receptor is widely dis-
tributed in kidney of rat (Chin et ai., 1992; 
Rabkin et ai., 1995) and man (Chin et ai., 1994; 
Chin and Bondy, 1992). 
Six mouse IGFBPs have been cloned (Schuller et 
ai., 1994), each of them showing specific expression 
patterns during embryonic development (Schuller et 
ai., 1993). During development of the human kid-
ney abundant expression is seen for IGFBP-2 and 
-4 in nephrogenic zones and epithelial cells of the 
maturing glomerulus, while moderate expression is 
seen for IGFBP-3 in epithelial cells of the ureteric 
bud and for IGFBP-5 in originating mesenchymal 
cells (Matsell et ai., 1994). In the mature rat kid-
ney glomerular and tubular expression is described 
for IGFBP-2 and -4, where as IGFBP- 3 and -5 
were mainly interstitially expressed (Rabkin et ai., 
1995; Price et ai., 1995). Low expression of 
IGFBP-l is found in the adult human kidney 
(Chin et ai., 1994), while it has been well detected 
in the thick ascending limbs of Henle's Loop in 
rat (Chin et ai., 1992; Rabkin et ai., 1995; Price et 
ai., 1995). The discrete. spatial and temporal expres-
sion patterns of the IGFBP genes in kidney sup-
port their modulatory role in IGF action. 
To study kidney pathophysiology mouse models 
are often used. We therefore aimed in this study 
to examine the involvement of the IGF system in 
normal mouse kidney development. A non radioac-
tive in situ hybridization technique was performed 
in order to precisely localize the mRNAs of the 
IGF system in mouse fetal and postnatal kidneys. 
Total mRNA content for IGF-I, IGF-II, IGFBP-2,-
3 and - 5 in fetal and early postnatal kidneys was 
determined by quantitative RT-PCR. Combining 
both techniques resulted in a detailed description of 
the gene expression of the IGF system during 
mouse kidney development. 
2. Materials and methods 
The experimental procedures reported in this study 
were carried out in accordance with the Dutch Animal 
and Experimentation Act after approval was granted by 
the Ethical Committee on Animal Experimentation of 
the Erasmus University Rotterdam. 
2.1. Tissue isolation 
Kidneys were collected from BALB/c mice on fetal 
day E13, 14, 15, 17, 19 and postnatal day PO, 1, 3, 7, 
14. They were either stored in - 80°C for total RNA 
extraction or fixed in 4% paraformaldehyde, dehy-
drated and embedded in paraffin according to standard 
procedures. For in situ hybridization, 4 ,urn sections 
were cut on a microtome and mounted on 3-
aminopropyl trioxysilane-coated slides. Sections were 
dried at 37°C for 3 days. 
2.2. Probe preparation 
The IGFBP-2 to -6 cRNA probes were transcribed 
from templates described by (Schuller et ai., 1994) . As 
template for the IGFBP-l cRNA probe the mouse 
cDNA fragment Sph I-Sac1 was cloned into pTZ18R 
or pTZ19R (Pharmacia, Uppsala, Sweden) for the anti-
sense or sense probes, respectively. cDNAs encoding 
mouse IGF-I and -II were kindly provided by Dr G.I. 
Bell (Howard Hughes Medical Institute, Chicago, IL). 
Fragments were subcloned into pTZ18 and pTZ19 
(EcoRl for IGF-I and BamHI/Sac1 for IGF-II). A 265 
bp EcoRl/Sma 1 fragment of the rat type I IGF recep-
tor cDNA clone ligated in pGEM3 (Promega, 
Madison, WI) was kindly provided by Dr H. Werner 
and Dr D. LeRoith (National Institutes of Health, 
Bethesda, MD). Digoxigenin-11-UTP labeled RNA 
probes were prepared according to the manufacturer's 
prescription (Boehringer Mannheim GmbH, Biochem-
ica, Mannheim, Germany) using T7 or SP6 RNA poly-
merase. 
2.3. In situ hybridization 
Sections were dewaxed, hydrated and incubated in 
the following solutions: 0.2 N HCL, 0.3% Triton-X 100 
in PBS, 5 ,ug/ml Proteinase K (37°C), 4% formalin in 
PBS and finally acetylated with acetic anhydride diluted 
in 0.1 M triethanolamine (750 ,u1/200 ml). Until hy-
bridization sections were stored in a solution of 50% 
formamide in 2 x SSC at 37°C. For hybridization, 
probes were diluted in hybridization solution (50% 
deionized formamide, 10% dextran sulfate, 2 x SSC, 
1 x Denhardt's solution, 1 ,ug/ml tRNA, 250 ,ug/ml 
herring sperm DNA) to a concentration of 100 ng/ml, 
incubated at 68°C for 15 min and layered onto the 
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sections. Sections were hybridized overnight at 55°C in 
a humid chamber. Posthybridization washes were per-
formed at 45°C using the following steps: 50% for-
mamide in 2 x SSC, 50% formamide in 1 x SSC and 
0.1 x SSe. A 15 min incubation with RNase Tl (2 
U /ml in 1 mM EDT A in 2 x SSC) at 37°C was fol-
lowed by washes of 0.1 x SSC at 45°C and 2 x SSC at 
room temperature. The DIG-labeled hybrids were de-
tected by antibody incubation performed according to 
the manufacturer's prescription (Boehringer Mannheim 
GmbH, Biochemica, Germany) with following modifi-
cations. A 1 :2000 dilution of anti-digoxigenin (Fab) 
conjugated to alkaline phosphatase was used for a 2.5 h 
incubation at room temperature. Afterwards an extra 
washing step of 0.025% Tween in Tris buffered saline 
pH 7.5 was introduced. For staining, sections were 
layered with detection buffer (0.1 M Tris-HCl, 0.1 M 
NaCl, 0.05 M MgC12 pH 9.5) containing 0.33 mg/ml 
NBT (4-nitroblue tetrazolium chloride), 0.16 mg/ml 
BCIP (5-bromo-4-chloro-3-indolyl-phosphate), 7.5% 
PV A (polyvinylalcohol, m. w. 31 000- 50000 Aldrich 
Chemical Milwaukee, WI) and I mM levamisol (Sigma, 
St. Louis, MO). The colour reaction was performed in 
the dark and was stopped when the desired intensity of 
the resulting blue precipitate was reached. Sections were 
washed in 10 mM Tris-HCl, 1 mM EDTA pH 8.0, 
counterstained with PAS and Nuclear red solution, 
dehydrated with ethanol gradients and mounted with 
an ethanol based mounting medium Euparal (Chroma-
Gesellschaft, Stuttgart, Germany). Control sections for 
morphological analysis were stained with hematoxylin 
and eosin. 
2.4. RNA extraction 
RNA preparation was carried out according to the 
acidic phenol/chloroform method of Chomczynski and 
Sacchi (1987) from frozen samples conserved at -
80°e. Each time point was represented by a pool of 
corresponding mouse kidneys. The recovery of total 
RNA was measured by spectrophotometric analysis at 
260 nm and quality and quantity were verified on a 
1.5% agarose gel. Similar intensities were observed in 
all samples. 
2.5. Quantitative RT-PCR 
Quantitation of mRNA was done by the non-com-
petitive PCR method described by Pane et al. (1995). 
An absolute amount of mRNA molecules is calculated 
by interpolating the generated amount of PCR prod-
ucts from sample RNA into a titration curve obtained 
by amplifying a known number of synthetic RNA 
molecules containing the same sequence as the RNA to 
be quantitated. 
2.5.1. Preparation of standard RNA 
The synthetic mRNA used as standard was obtained 
in two steps. First, cDNA fragments containing the 
desired sequences were amplified by performing PCR 
on the available cDNAs of the mouse IGF system 
(Schuller et aI., 1993). After purification and densito-
metric quantitation, the fragments were ligated for 3 h 
at 15°C into the pGEM-T vector (Promega, Madison, 
WI). This vector contains the T7 promoter sequence 
and is specially adapted to ligate PCR fragments. A 
second PCR was performed using 1 ,ulligation mixture 
(1: 1 diluted) as DNA template, the T7 promoter se-
quence as 5'-primer (5'_ TGTAATACGACTCAC-
TATAGGGAGA-3') and gene specific 3'-primers 
(Table 1). This strategy resulted in a PCR fragment that 
contained the same sequence as to be quantitated plus 
the T7 promoter sequence. This T7-fragment was 
purified and used for in vitro RNA transcription (Ribo-
MAX kit, Promega, Madison, WI). The produced 
cRNA was purified by phenol-chloroform extraction 
and Sephadex G50 column elution. The number of 
molecules was calculated by using the molecular weight 
of the cRNA molecule, Avogadro's number and the 
spectrophotometric absorbance at 260 nm. 
2.5.2. RT-PCR 
RT-PCR was performed on both prepared stan-
dard RNA and extracted sample RNA One micro-
gram total RNA was reverse transcribed with 200 
units of M-MLV reverse transcriptase (Gibco BRL) 
primed with specific 3'-primers for IGF-I, IGF-
Table I 
Sequences of PCR primers and predicted PCR products 
Amplified mR- Sense and antisense primers Size of amplified 
NAs products (bp) 
IGF-I 5'-AAAATCAGCAGTCT-
TCCAAC-3' 
5'-AGATCACAG CTCCG- 299 
GAAGCA-3' 
IGF-II 5'-GCCCCGGAGAGACT-
CTGTGCG-3' 
5'-GCCCACGGGGTATC- 253 
TGGGGAA-3' 
IGFBP-2 5'-TGGAGGAGCCCAA-
IGFBP-3 
IGFBP-5 
GAAGCT-3' 
5'-GGTTCACACACCAG- 228 
CAACTC-3' 
5' -GCCGCGGGCTCT-
GCGTCAACGC-3' 
5'-CTGGGACTCAGCA- 415 
CA TTGAGGAAC-3' 
5' -TTGCCTCAACGAAA-
AGAGC-3' 
5'-AGAATCCTTTGCG- 377 
GTCACA-3' 
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II, IGFBP-2, -3 and -5 (Table 1) in a final volume of 20 
.ul. The PCR reaction was carried out in a final volume 
of 50 .ul with the equivalent of 50 ng of total RNA (5 
.ul of a 1:5 dilution of the Reverse Transcription reac-
tion) in PCR buffer (50 mM KCl, 1.5 mM MgClb and 
20 mM Tris-HCl, pH 8.3) plus 200 .uM deoxy-NTPs, 
[a-p32jdATP, 25 pmol forward and reverse primers and 
1 U of Hi-Taq DNA Polymerase (Bioprobe Systems, 
France). PCR reactions were performed separately us-
ing an initial denaturation at 94°C for 3 min, followed 
by 25 cycles that included: 30 s at 94°C, 20 s annealing 
at 53°C (except for IGFBP-2, 45°C) and 30 s at n°e. 
Products were analysed on a 2.5% agarose gel and 
bands corresponding to each specific PCR product were 
excised and the amount of incorporated radioactivity 
was determined by fJ -scintillation counting. Oligonucle-
otide primers designed for the amplification were pur-
chased from Pharmacia Biotech (The Netherlands). 
2.6. Statistical analysis 
The differences in expression levels during develop-
ment were scored for significance using the one-way 
analysis of variance (ANOV A), followed by a Scheffe F 
test. Level of significance was chosen at P < 0.05. 
3. Results 
Development of the mouse kidney starts at fetal day 
E10 when the ureteric bud emerges and invades the 
mesenchyme. The resulting appositional development 
of renal vesicles continues until the early postnatal 
period. All stages can be recognized in sections of 
mouse fetal day E15 (staging performed according to 
Saxen (1987)) and were therefore used to present the 
expression patterns in developing structures (Fig. 
lA,lB). The mRNA expression patterns in mature 
structures (Fig. 1 C) are represented by data from kid-
neys at postnatal day P14. Scoring based on results 
from the in situ hybridization of E15 and P14 are listed 
in Tables 2 and 3, respectively. Results from the RT-
PCR quantitation are presented in Fig. 5. 
3.1. In situ hybridization 
3.1.1. IGF-I mRNA 
A scattered pattern of IGF-I mRNA expression in all 
cell types was observed during kidney development 
(Fig. 2A). The expression pattern at birth was confined 
to the epithelial cells of both layers of Bowman's cap-
sule and the epithelial cells of cortical tubules. After 
day P7 a rather drastic decrease was seen in the proxi-
mal tubules and at day P14 most of the hybridization 
signal was found in the peritubular capillaries of the 
outer medulla and inner cortex (Fig. 4A). 
BP·3 
lA 
Ie ~~~, 
Fig. 1. Schematic illustration of the main expression sites of the IGF 
system in the developing mouse kidney. (lA) Developmental stages 
during nephrogenesis including: early condensate (ec); pretubular 
condensate (pc); comma-shaped body (C); and S-shaped nephron (S). 
(lB) Developing glomerulus. (lC) Mature nephron. Abbreviations 
are: c, capsule; m, mesenchyme; e, endothelial cells; a, ampulla; U, 
ureteric bud; p, parietal epithelial layer; ca, capillary; j, juxtaglomeru-
lar cells. 
3.1.2. IGF-II mRNA 
At different fetal stages strong hybridization signals 
for IGF-II mRNA were detected in differentiating mes-
enchymal and epithelial cells, as well as endothelial 
cells. No signals were detected in epithelial cells of the 
ampulla of the ureteric bud (Fig. 2B). Prominent ex-
pression sites were the ureteric bud, parietal and vis-
ceral epithelial layers of the nephric bodies (Fig. 2B) 
and developing proximal tubules (Fig. 4B). After devel-
opment most cells showed reduction of IGF-II mRNA 
expression, except for endothelial cells of renal vessels. 
Faint signals were present in epithelial cells of Bow-
man's capsule. 
3.1.3. Type I receptor mRNA 
The type I receptor mRNA was expressed in all cells 
of the kidney during fetal development (Fig. 2C). Con-
tinuous expression from fetal stage until maturity was 
observed in visceral and parietal epithelial layers of 
developing glomeruli and in epithelial cells of distal and 
collecting tubules (Fig. 4C). Type I receptor mRNA 
expression was found in proximal tubules until birth 
and until day P7 the thick limbs of Henle's Loop (Fig. 
4C) showed expression. Faint hybridization signals 
were observed at day P14. 
3.1.4. IGFBP-1 mRNA 
Little or no expression was seen in fetal kidney for 
IGFBP-1 (Fig. 2D). At day P14 faint signals could be 
observed in some cells of the proximal tubules, distal 
tubules and the epithelial cells of Bowman's capsule, 
while strong signals were seen in control liver sections 
(data not shown). 
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Table 2 
Expression of IOF system in structures of developing mouse kidney at day El5 
IOFI IOF II tlrec BPI BP2 BP3 BP4 BP5 BP6 
Renal capsule + + + + ++ + 
Mesenchymal cells + + + + + + + + 
Early condensate + ++ + + ++ 
Pretubular condensate + ++ + + + 
Endothelial cells + + + + ++ + + + 
Ureteric bud + + + + ++ 
Ampulla + + + 
Branching area + + ++ 
Comma- and S-shaped bodies and developing glomeruli 
Invading endothelial cells + + + ++ + 
Mesangial cells + + + + ++ 
Visceral epithelial layer + + + 
Parietal epithelial layer + ++ + ++ + + 
Developing tubules + + + + + ++ 
Scoring: - no signal above background; + low abundance; + + high abundance. Scoring is based on observations in a minimum of three kidney 
sections obtained from at least two animals. 
3.1.5. IGFBP-2 mRNA 
Early stages of developing kidney showed abundant 
hybridization signals for IGFBP-2 mRNA in the 
ureteric bud and the surrounding mesenchyme. At day 
El5 hybridization signals were strong in the branching 
area of the ureteric bud (Fig. 2E and Fig. 4D) and the 
parietal epithelial layer of the developing nephric bodies 
(Fig. 3A). During maturation expression in the 
glomerulus was expanded to the visceral epithelial layer 
and at day Pl4 both layers of Bowman's capsule con-
tributed to the IGFBP-2 mRNA expression pattern. In 
contrast to a postnatal decrease of hybridization signals 
in developing proximal tubules, an increase could be 
observed in the thin limbs of Henle's Loop, being very 
strong at day Pl4 (Fig. 4E). 
3.1.6. IGFBP-3 mRNA 
Single cells within the population of mesenchymal 
cells expressed IGFBP-3 mRNA from day E13 on (Fig. 
2F). Endothelial cells of the invading capillary loop 
showed strong expression in the S-shaped nephron 
stage (Fig. 3B) and during maturation of the 
glomerulus (Fig. 3D,3F). However in the mature 
glomerulus no IGFBP-3 mRNA was detected anymore 
(Fig. 3H). IGFBP- 3 mRNA expression sites at day P14 
were the peri tubular capillaries in the cortex (Fig. 3H) 
and to a lesser extent those in the medulla. 
3.1.7. IGFBP-4 mRNA 
The IGFBP-4 gene was expressed in mesenchymal 
cells of the developing kidney, showing more signal in 
the pretubular condensate and in cells enclosed in the 
nephric bodies and developing glomeruli. No expres-
sion was seen in epithelial cells of the ureteric bud and 
the comma-and S-shaped bodies, while epithelial cells 
of more developed tubules did express IGFBP-4 
mRNA (Fig. 2G). At day Pl4 the main sites of expres-
sion were the proximal tubules including their straight 
segments (Fig. 4F) and peritubular capillaries in the 
outer medulla. 
3.1.8. IGFBP-5 mRNA 
The epithelial cell layer of the renal capsule and the 
underlaying outer zone of the metanephric blastema 
expressed IGFBP-5 mRNA throughout nephrogenesis 
(Fig. 2H). A very marked expression was observed in 
mesenchymal cells forming the early condensate (Fig. 
2H) and those destined to become mesangial cells in 
developing glomeruli (Fig. 3C). Hybridization signals 
for IGFBP-5 mRNA were found in epithelial cells of 
developing proximal tubules (Fig. 4H) and of the 
ureteric bud, except its ampulla (Fig. 2H). The expres-
sion pattern changed as the kidney matured, showing a 
decrease in proximal tubules from day P7 on and a very 
strong expression arising in peritubular capillaries of 
the medulla (Fig. 4G). IGFBP-5 mRNA could also be 
detected in peri tubular capillaries and distal tubules of 
the cortex and abundant expression was present in 
mesangial cells and in juxtaglomerular cells of the 
glomeruli (Fig. 3E,3G). 
3.1.9. IGFBP-6 mRNA 
IGFBP-6 mRNA was very weakly expressed during 
nephrogenic stages in epithelial cells (Fig. 21), but after 
birth expression could be observed in the visceral ep-
ithelial layer and podocytes of developing glomeruli 
and collecting tubules. At day Pl4 no hybridization 
signals were seen. As positive controls, liver sections 
showed good hybridization signals. 
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Table 3 
Expression of IGF system in mouse kidney at day PI4 
IGF I IGF II tlrec BPI BP2 BP3 BP4 BP5 BP6 
Glomeruli 
Capillaries 
Mesangial cells + ++ 
Bowman's capsule + + + + ++ 
Juxtaglomerular cells ++ 
Peritubular capillaries 
Outer cortex ++ + 
Inner cortex + 
Outer medulla ++ + + ++ 
Inner medulla + + ++ 
Distal tubules + + + + ++ 
Proximal tubules + ++ + 
Thick limb of Henle's Loop + + + 
Thin limb of Henle's Loop ++ 
Scoring: - no signal above background; + low abundance; + + high abundance. Scoring is based on observations in a minimum of three kidney 
sections obtained from at least two animals 
Renal vessels expressed IGFBP-2,-3,-4 and -5 mRNA 
throughout development (data not shown). 
3.2. Quantitative RT-PCR 
The amount of IGF-II and IGFBP-2 mRNA 
molecules was high during renal development and for 
both the same profile was observed: after a significant 
rise towards birth a postnatal decline started. Lower 
fetal levels were measured for IGF-I, IGFBP-3 and -5 
mRNA and after birth all three began to increase 
significantly (Fig. 5). 
4. Discussion 
This study has shown well defined spatial and tempo-
ral mRNA expression profiles of the members of the 
IGF system during mouse nephrogenesis. Our presenta-
tion is to our knowledge. a first combination of data 
from non radioactive in situ hybridization and quanti-
tative RT-PCR, resulting in optimal cellular localiza-
tion and reliable quantitation. 
As non radioactive in situ hybridization was meant 
for optimal localization, the colour reaction was 
stopped when discriminate hybridization signals with 
maximum intensities were reached. The quantitative 
RT-PCR compensated for possible variations in probe 
specificity, UTP content or hybridization conditions 
and resulted in absolute amounts of mRNA molecules 
measured. 
We have observed distinct expression patterns for the 
IGFs, the type I receptor and the six IGFBPs through-
out kidney development. The widespread moderate ex-
pression of type I receptor mRNA is compatible with 
its IGF-I and -II signal transducing role. On the other 
hand, the specifically localized expression of the IGFBP 
mRNAs is supportive for their modulatory role in IGF 
actions. The half life of the IGFs is prolonged by 
binding to the IGFBPs, which in circulation function as 
carrier proteins providing a reservoir of IGFs. In addi-
tion, locally produced IGFBPs can regulate the 
availability of IGFs in the vicinity of their receptors 
and thus modulate their actions (Liu et aI., 1994). 
The inverse quantitation profiles for IGF-I and IGF-
II do suggest their distinct role in different stages of 
development. High prenatal levels of IGF-II mRNA 
confined to sites of cellular differentiation support a 
vital function in nephrogenesis, while increasing levels 
of IGF-I after birth emphasize its role in postnatal 
kidney physiology. In the mature kidney localization of 
IGF-I and type I receptor mRNA in the distal tubules 
favour the involvement of IGF in transmembrane 
transport of for instance Na + and tubular inorganic 
phosphate (Pi), as has been suggested by others 
(Kobayashi et aI., 1995; Caverzasio et aI., 1990). Their 
presence in epithelial cells of the glomerulus might 
indicate an involvement in regulation of glomerular 
filtration processes (Hirschberg et aI., 1991). 
Close interactions of the IGFs and their binding 
proteins in developing and physiological processes are 
indicated by their overlapping or adjacent expression 
sites and parallelling quantitation profiles. 
The low hybridization signals for IGFBP-l mRNA 
that we detected in the mouse kidney correspond with 
the findings of Chin et aI. (Chin et aI., 1994; Chin and 
Bondy, 1992) in human kidneys. On the other hand, 
IGFBP-l is well expressed in rat (Rabkin et aI., 1995; 
Chin and Bondy, 1992; Price et aI., 1995) and levels 
were shown to be influenced by long-term diabetes 
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Fetal expression 
Fig. 2. Photomicrographs of in situ hybridization with DIG-labeled cRNA probes in developing mouse kidneys at day E15. The blue coloured 
precipitate corresponds to sites of mRNA expression of (A) IGF-I, (B) IGF-I1, (C) type I receptor, (D) IGFBP-l, (E) IGFBP-2, (F) IGFBP-3, 
(G) IGFBP-4, (H) IGFBP-5, (I) IGFBP-6. Abbreviations are: u, ureteric bud; a, ampulla; m, mesenchyme; ec, early condensate; C, Comma-shaped 
body; S, S-shaped body; G, glomerulus; p, parietal epithelial cells; v, visceral epithelial cells; b, branching area of the ureteric bud; rc, renal 
capsule; c, capillary loop. Arrows ('-,.) indicate expression sites of IGFBP-3 in the early capillary network. Scale bar = 50 jiM. 
(Landau et aI., 1995). These data may indicate a species 
difference for the role of renal IGFBP-1 in mediating 
autocrine or paracrine IGF actions. 
A striking similarity was observed in the profiles of 
mRNA levels for IGFBP-2 and IGF-II during nephro-
genesis. High prenatal IGFBP-2 mRNA levels which 
peaked around birth and decreased postnatally, were 
mimicked by IGF-II. This not only demonstrates the 
importance of both genes during fetal and perinatal 
kidney development, but also indicates a close interac-
tion in gene regulation, as has been proposed by others 
(Delhanty and Han, 1993; Carr et aI., 1995). Strong 
IGFBP-2 hybridization signals were confined to in-
duced differentiating cells in the branching area of the 
ureteric bud. They support a role for IGFBP-2 in 
nephrogenic IGF-II actions. Like in rat (Rabkin et aI., 
1995; Chin and Bondy, 1992; Price et aI., 1995) and 
man (Matsell et aI., 1994; Chin et aI., 1994; Chin and 
Bondy, 1992) IGFBP-2 mRNA was confined to the 
epithelial cells in the mature glomerulus and here its 
protein might bind circulating or locally produced IGF 
and facilitate the translocation of vascular IGF into the 
tubular compartments for renal clearance (Chin and 
Bondy, 1992). A similar function has been suggested in 
brain (Bondy et aI., 1992). High expression in the thin 
limbs of Henle's Loop accorded with IGFBP-2 mRNA 
(Rabkin et aI., 1995; Price et aI., 1995) and IGFBP-2 
protein (Evan et aI., 1995) data in rat kidney. By 
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Glomerular expression 
Fig. 3. Photomicrographs of in situ hybridization with DIG-labeled cRNA probes in the developing stages of glomeruli in mouse kidney. (A) 
IGFBP-2 at day E15, (8, D, F, H) IGFBP-3 at day E15, E15, P7 and P14, respectively. (C, E, G) IGFBP-5 at day E15, P7 and P14, respectively. 
Abbreviations are: u, ureteric bud; S, S-shaped body; G, glomerulus; p, parietal epithelial cells; v, visceral epithelial cells; c, capillary; rna, 
mesangial cells; pt, proximal tubule; d, distal tubule; j, juxtaglomerular cells; • indicates erythrocyte present in capillary; arrow"" in (8) points 
to IGFBP-3 expressing endothelial cell in the mesenchyme. Scale bar = 50 ,uM. 
influencing the amount of available IGF-II, IGFBP-2 
might modulate IGF-II action in Na + jH + exchange 
across the membranes of the epithelial cells, as has been 
demonstrated in cultured proximal tubular cells (Mellas 
et aI., 1986). 
The higher IGF-I mRNA levels after birth coincided 
with increased production of IGFBP- 3 mRNA, which 
we find in the mouse kidney exclusively located in the 
capillary system. Our precise cellular localization confi-
rms the suggested expression sites of IGFBP-3 in rat 
(Rabkin et aI., 1995). Expression of IGFBP-3 in the 
capillary system may emphasize its main function in 
being a carrier protein for circulating IGFs. In addi-
tion, IGFBP-3 is involved in local actions of IGF, like 
vascularization (Nakao-Hayashi et aI., 1992). The pres-
ence of IGFBP-3 in single cells of the mesenchyme, 
often accompanied by erythrocytes, fits with the as-
sumption that these are endothelial cells, forming the 
capillary system of the fetal kidney (Pinson Hyink and 
Abrahamson, 1995). This defined localization correlates 
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(Peri-)tubular expression 
Fig. 4. Photomicrographs of in situ hybridization with DIG-labeled cRNA probes in developing and matured tubules in mouse kidney. (4A) IGF-I 
at day Pl4 in peritubular capillaries ( ..... ) in ICjOM, (48) IGF-II at day E15, (4C) type I receptor at day P7 in ICjOM, (4D). IGFBP-2 at day 
E15, (4E) IGFBP-2 at day Pl4 in the medulla, (4F) IGFBP-4 at day P14, (4G) IGFBP-5 at day Pl4 in the medulla, (4H) IGFBP-5 at day E15. 
Abbreviations are: G, glomerulus; pt, proximal tubule; p, parietal epithelial cells; T, thick limb of Henle's loop; u, ureteric bud; dp, developing 
proximal tubule; d, distal tubule; rna, mesangial cells; ct, collecting tubule; c, peritubular capillary; rc, renal capsule; b, branching area of the 
ureteric bud; m, mesenchyme; tl, thin limb of Henle's loop; ., indicates erythrocytes present in capillary. Arrowhead points to the medullary 
region. Scale bar = 50 JLM. 
well with the observed expression in human nephro-
genic mesenchyme (Matsell et aI., 1994). Until matura-
tion IGFBP-3 mRNA was expressed in the invading 
endothelial cells, forming the capillary loop of the 
developing glomerulus. Besides its possible role here in 
vascularization, IGFBP-3 might also act as a provider 
of IGFs to have their effect on the formation of the 
glomerular basement membrane (GBM) and the pro-
duction of the extracellular matrix (ECM) in the 
mesangial cells (Pricci et aI., 1996). IGFBP-3 was no 
longer expressed in the mature glomerulus, however 
during severe glomerulosclerosis in diabetic growth hor-
mone transgenic mice IGFBP-3 mRNA is again ex-
pressed in the capillaries of the glomeruli (manuscript 
in preparation). This resumption of IGFBP-3 mRNA 
expression could be a result of elevated IGF-I levels 
(Clemmons et aI., 1989; Bach and Jerums, 1990; Flyvb-
jerg et aI., 1990) perhaps to enhance IGF action (Blum 
et aI., 1989) in the expansion of mesangial ECM (Doi et 
aI., 1989). 
Expression patterns for IGFBP-5 mRNA in mouse 
were similar to those in man (Matsell et aI., 1994; Chin 
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et ai., 1994) and rat (Rabkin et ai., 1995; Price et ai., 
1995). In the developing mouse kidney, IGFBP-5 
mRNA co-localized with IGF-II mRNA at sites of 
cellular differentiation. This might imply a role for 
IGFBP-5 in potentiating IGF-II action as also has been 
described for osteoblasts in vitro (Andress and Birn-
baum, 1992). Involvement in functional processes in the 
kidney is made likely by the increase in mRNA levels 
after birth. High IGFBP-5 mRNA expression in mesan-
gial cells persisted in the mature glomerulus and ex-
panded with the migration of the mesangial cells into 
the juxtaglomerular cells. Taking into account that 
IGFs have a stimulatory effect on the glomerular filtra-
tion rate (GFR) (Hirschberg et ai., 1991), we might 
assume a mediating role for IGFBP-5 in this process. In 
vitro studies showed that ionic strength influences 
IGFBP-5 binding to ECM. Bound to ECM IGFBP-5 
has a reduced affinity for IGFs, while being in solution 
its affinity increases (Jones et ai., 1993). In this way 
IGFBP-5 can influence the availability of IGFs for their 
receptors and as a result the IGF actions in the vicinity 
of the glomerular filtration apparatus. The IGFBP-5 
mRNA expression described in rat (Rabkin et ai., 1995; 
Price et ai., 1995) and human (Matsell et aI., 1994; Chin 
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Fig. 5. (SA) Quantitation profiles for mRNA of IGF-II and IGFBP-2 
during mouse kidney development. Data represent the means (n = 4-
6) ± S.E.M. ** Significant compared to El7 (P < 0.02); not significant 
compared to P3 (P < 0.06). * Significant compared to EI7 (P < 0.03). 
# # Significant compared to PI (P < 0.02). # Significant compared 
to EI7 and P3 (P < 0.05). (5B). Quantitation profiles for mRNA of 
IGF-I, IGFBP-3 and -5 during mouse kidney development. Data 
represent the means (n = 4-6) ± S.E.M. ** Significant compared to 
EI9 for all genes (P < 0.02). 
et ai., 1994) medullary interstitium supports our defined 
localization in the peritubular capillaries of the 
medulla. The presence here of IGFBP-5 indicates an 
involvement in the IGF stimulated ion transport and 
exchange in the surrounding tubules (Zumkeller and 
Scofield, 1992). 
In summary, we have shown that a combination of 
non radioactive in situ hybridization and quantitative 
RT-PCR results in a well defined localization and 
quantitation of mRNA expression. Our results demon-
strate that during mouse kidney development each 
member of the IGF system has its specific mRNA 
expression pattern and altering mRNA levels. Distinct 
roles for each of them can be proposed in renal devel-
opment and physiology and therefore our findings 
might be helpful to interpret observations of patho-
physiological conditions. 
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